These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23605506)

  • 1. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
    Darwish M; Kirby M; Robertson P; Tracewell W; Xie F
    Clin Drug Investig; 2010; 30(6):365-73. PubMed ID: 20441245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers.
    Rauck R; Oh DA; Parikh N; Koch C; Singla N; Yu J; Nalamachu S; Vetticaden S
    Curr Med Res Opin; 2017 Nov; 33(11):1915-1920. PubMed ID: 28681626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
    Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
    Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
    Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
    Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 27933600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study.
    Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Yu J; James S
    Clin Drug Investig; 2018 Aug; 38(8):715-726. PubMed ID: 29909433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
    Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
    Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 22128878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Pharmacokinet; 2005; 44(12):1279-86. PubMed ID: 16372825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.
    Lennernäs B; Hedner T; Holmberg M; Bredenberg S; Nyström C; Lennernäs H
    Br J Clin Pharmacol; 2005 Feb; 59(2):249-53. PubMed ID: 15676050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers.
    Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Wilson D; Yu J; Vetticaden S
    Curr Med Res Opin; 2017 Nov; 33(11):1921-1933. PubMed ID: 28942715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, safety, and tolerability of ascending doses of sublingual fentanyl, with and without naltrexone, in Japanese subjects.
    Lister N; Warrington S; Boyce M; Eriksson C; Tamaoka M; Kilborn J
    J Clin Pharmacol; 2011 Aug; 51(8):1195-204. PubMed ID: 21209242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
    Plock N; Facius A; Hartmann L; Baumann S; Nave R
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
    Minkowitz H; Bull J; Brownlow RC; Parikh N; Rauck R
    Support Care Cancer; 2016 Jun; 24(6):2669-75. PubMed ID: 26780504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
    Vasisht N; Gever LN; Tagarro I; Finn AL
    Clin Drug Investig; 2009; 29(10):647-54. PubMed ID: 19715381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects.
    Nave R; Schmitt H; Popper L
    Drug Deliv; 2013; 20(5):216-23. PubMed ID: 23650968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 - 800 µg in healthy volunteers.
    Fisher A; Watling M; Smith A; Knight A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):860-7. PubMed ID: 21084042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.